Hitomi Kurinami

2.3k citations

38 papers · 1.9k indexed · h-index 25

Physiology top 5%
Molecular Biology
Neurology top 2%
Cellular and Molecular Neuroscience top 5%
Surgery

Co-authors: Ryuichi Morishita Naoyuki Sato Munehisa Shimamura Hiromi Rakugi Daisuke Takeuchi Shuko Takeda Mitsuru Shinohara Toshio Ogihara
Topics: Alzheimer's disease research and treatments (7 papers)Neuroinflammation and Neurodegeneration Mechanisms (5 papers)Computational Drug Discovery Methods (5 papers)
Cited by: Neurology Physiology Biological Psychiatry
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Circulation
Partner nations: Japan France United States

In The Last Decade

Hitomi Kurinami

38 papers receiving 1.8k citations

Peers

Countries citing papers authored by Hitomi Kurinami

Since Specialization

Citations

This map shows the geographic impact of Hitomi Kurinami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitomi Kurinami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitomi Kurinami more than expected).

Fields of papers citing papers by Hitomi Kurinami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitomi Kurinami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitomi Kurinami. The network helps show where Hitomi Kurinami may publish in the future.

Co-authorship network of co-authors of Hitomi Kurinami

This figure shows the co-authorship network connecting the top 25 collaborators of Hitomi Kurinami. A scholar is included among the top collaborators of Hitomi Kurinami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitomi Kurinami. Hitomi Kurinami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The utility of the ultrasonographic assessment of the lower leg muscles to evaluate sarcopenia and muscle quality in older adults 2020 ·SHILAP Revista de lepidopterología ·M. Isaka,Ken Sugimoto,Taku Fujimoto,(unknown),(unknown),(unknown),(unknown),Toshimasa Takahashi,Hitomi Kurinami,Hiroshi Akasaka,Yasushi Takeya,Kōichi Yamamoto,Hiromi Rakugi	4
2	A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling 2019 ·SHILAP Revista de lepidopterología ·Ryo Nakamaru,Kōichi Yamamoto,Satoko Nozato,Kazuhiro Hongyo,(unknown),Hideharu Hagiya,Futoshi Nakagami,Hiroshi Akasaka,Hitomi Kurinami,Yoichi Takami,Yasushi Takeya,Ken Sugimoto,Takeshi Ujike,Motohide Uemura,Norio Nonomura,Hiromi Rakugi	2
3	The Usefulness of an Alternative Diagnostic Method for Sarcopenia Using Thickness and Echo Intensity of Lower Leg Muscles in Older Males 2019 ·Journal of the American Medical Directors Association ·M. Isaka,Ken Sugimoto,(unknown),Hiroshi Akasaka,Taku Fujimoto,Hitomi Kurinami,Yasushi Takeya,Kōichi Yamamoto,Hiromi Rakugi	38
4	Overexpression of Interleukin-15 exhibits improved glucose tolerance and promotes GLUT4 translocation via AMP-Activated protein kinase pathway in skeletal muscle 2019 ·Biochemical and Biophysical Research Communications ·Taku Fujimoto,Ken Sugimoto,Toshimasa Takahashi,(unknown),(unknown),Minoru Tanaka,(unknown),(unknown),Hitomi Kurinami,Hiroshi Akasaka,Yoichi Takami,Yasushi Takeya,Kōichi Yamamoto,Hiromi Rakugi	27
5	A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke 2016 ·Scientific Reports ·Hitomi Kurinami,Munehisa Shimamura,Hironori Nakagami,Hideo Shimizu,Hiroshi Koriyama,Tomohiro Kawano,Kouji Wakayama,Hideki Mochizuki,Hiromi Rakugi,Ryuichi Morishita	31
6	Possible modification of Alzheimerâ€™s disease by statins in midlife: interactions with genetic and non-genetic risk factors 2014 ·Frontiers in Aging Neuroscience ·(unknown),Naoyuki Sato,Munehisa Shimamura,Hitomi Kurinami,Toshimitsu Hamasaki,Amarnath Chatterjee,Hiromi Rakugi,Ryuichi Morishita	41
7	Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a) 2013 ·Scientific Reports ·(unknown),Hironori Nakagami,Hiroshi Koriyama,Futoshi Nakagami,Munehisa Shimamura,Hitomi Kurinami,H. Tomioka,Takashi Miyake,Tomohiro Katsuya,Ryuichi Morishita	6
8	Do Angiotensin Receptor Blockers Protect Against Alzheimer’s Disease? 2013 ·Drugs & Aging ·Hitomi Kurinami,Munehisa Shimamura,Naoyuki Sato,Hironori Nakagami,Ryuichi Morishita	16
9	Development of novel DNA vaccine for VEGF in murine cancer model 2013 ·Scientific Reports ·(unknown),Hironori Nakagami,Hiroshi Koriyama,H. Tomioka,Futoshi Nakagami,Munehisa Shimamura,Hitomi Kurinami,Zheng‐Da Pang,Dong Hyun Jo,Jeong Hun Kim,Nobuyuki Takakura,Ryuichi Morishita	15
10	Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes 2010 ·Proceedings of the National Academy of Sciences ·Shuko Takeda,Naoyuki Sato,Kozue Uchio‐Yamada,Jun Wada,Takanori Kunieda,Daisuke Takeuchi,Hitomi Kurinami,Mitsuru Shinohara,Hiromi Rakugi,Ryuichi Morishita	407
11	Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance 2010 ·Journal of Biological Chemistry ·(unknown),Naoyuki Sato,Hitomi Kurinami,Daisuke Takeuchi,Shuko Takeda,Munehisa Shimamura,Toshihide Yamashita,Yasuo Uchiyama,Hiromi Rakugi,Ryuichi Morishita	99
12	Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease 2009 ·Brain Research ·Shuko Takeda,Naoyuki Sato,Kazue Niisato,Daisuke Takeuchi,Hitomi Kurinami,Mitsuru Shinohara,Hiromi Rakugi,Masanobu Kano,Ryuichi Morishita	49
13	Elevation of plasma β-amyloid level by glucose loading in Alzheimer mouse models 2009 ·Biochemical and Biophysical Research Communications ·Shuko Takeda,Naoyuki Sato,Kozue Uchio‐Yamada,Jun Wada,Takanori Kunieda,Daisuke Takeuchi,Hitomi Kurinami,Mitsuru Shinohara,Hiromi Rakugi,Ryuichi Morishita	22
14	Alleviation of Aβ-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model 2008 ·Gene Therapy ·Daisuke Takeuchi,Naoyuki Sato,Munehisa Shimamura,Hitomi Kurinami,Shunichi Takeda,(unknown),Shingo Suzuki,Masami Kojima,Toshio Ogihara,Ryuichi Morishita	33
15	Development of new screening system for Alzheimer disease, in vitro Aβ sink assay, to identify the dissociation of soluble Aβ from fibrils 2006 ·Neurobiology of Disease ·Naoyuki Sato,Masayasu Okochi,Yoshiaki Taniyama,Hitomi Kurinami,Munehisa Shimamura,Daisuke Takeuchi,(unknown),Akio Fukumori,Kazuyuki Kiyosue,Takahisa Taguchi,Toshiyuki Tanaka,Masayuki Miyasaka,Masatoshi Takeda,Toshio Ogihara,Ryuichi Morishita	6
16	Clinical Trial of Human Gene Therapy Using Hepatocyte Growth Factor Gene Transfer(Translational Research in Cardiovascular Disease, The 69th Annual Scientific Meeting of the Japanese Circulation Society) 2005 ·Japanese Circulation Journal-english Edition ·Motokuni Aoki,Ryuichi Morishita,Hirofumi Makino,Naotaka Hashiya,(unknown),Yasushi Takeya,Hitomi Kurinami,Toshio Ogihara	1
17	Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles 2005 ·The Journal of Gene Medicine ·Munehisa Shimamura,Naoyuki Sato,Yoshiaki Taniyama,Hitomi Kurinami,Hiroyuki Tanaka,Toshihiro Takami,Toshio Ogihara,Masaya Tohyama,Yasufumi Kaneda,Ryuichi Morishita	45
18	Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones 2004 ·Genes to Cells ·(unknown),Tatsuo Furuyama,(unknown),(unknown),Hitomi Kurinami,Shinobu Inagaki	68
19	Increase in Peripheral Blood Flow by Intravenous Administration of Prostaglandin E1 in Patients with Peripheral Arterial Disease, Accompanied by Up-Regulation of Hepatocyte Growth Factor 2004 ·Hypertension Research ·Hirofumi Makino,Motokuni Aoki,Naotaka Hashiya,Keita Yamasaki,Kazuya Hiraoka,Hideo Shimizu,Junya Azuma,Hitomi Kurinami,Toshio Ogihara,Ryuichi Morishita	24
20	Sema4C, a Transmembrane Semaphorin, Interacts with a Post-synaptic Density Protein, PSD-95 2001 ·Journal of Biological Chemistry ·Shinobu Inagaki,Yoshiharu Ohoka,(unknown),(unknown),(unknown),Hitomi Kurinami,(unknown),Masaya Tohyama,Tatsuo Furuyama	54

About Hitomi Kurinami

Hitomi Kurinami is a scholar working on Neurology, Developmental Neuroscience and Rehabilitation, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (5 papers). The work is most often cited by research in Neurology (372 citations), Physiology (668 citations) and Biological Psychiatry (61 citations). Hitomi Kurinami has collaborated with scholars based in Japan, France and United States. Frequent co-authors include Ryuichi Morishita, Naoyuki Sato, Munehisa Shimamura, Hiromi Rakugi, Daisuke Takeuchi, Shuko Takeda, Mitsuru Shinohara, Toshio Ogihara, Takanori Kunieda and Kozue Uchio‐Yamada. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact